ArabicChineseEnglishFrenchRussianSpanish
WHO home
All WHO This site only
  Immunization, Vaccines and Biologicals
  WHO > WHO sites > Immunization, Vaccines and Biologicals > IVB Topics
printable version

Haemophilus influenzae type b (Hib): Previous page | 1,2,3,4

Hib - The vaccine

  Table of contents for Hib

What is Haemophilus influenzae type b vaccine?

Haemophilus influenzae type b vaccine prevents meningitis, pneumonia, epiglottitis, and other serious infections caused by Haemophilus influenzae type b bacteria. The vaccine will not protect against these conditions if they are caused by other agents. Hib vaccine is available in two forms, liquid or freeze-dried. Each is available as monovalent vaccine or in combination with other vaccines. Many countries give Hib combined with DTP and HepB vaccines (DTP-HepB+Hib) (see Section 10 of this Module).

How safe is Hib vaccine and what are its potential side-effects?

Haemophilus influenzae type b vaccine is very safe. There are no known serious reactions to the vaccine. Mild reactions include:

  • Soreness: About 5% to 15% of those who receive Hib vaccine develop redness, swelling, or mild pain at the site of the injection.
  • Fever: A short time after immunization, between 2% and 10% of people may develop a mild ever.

Haemophilus influenzae type b (Hib): 1,2,3,4 | Next page

[an error occurred while processing this directive]